{"name":"Freya Biosciences ApS","slug":"freya-biosciences-aps","ticker":"","exchange":"","domain":"freyaaps.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"FB 301","genericName":"FB 301","slug":"fb-301","indication":"Treatment of type 2 diabetes","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"metronidazole 500 mg","genericName":"metronidazole 500 mg","slug":"metronidazole-500-mg","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"FB 301","genericName":"FB 301","slug":"fb-301","phase":"phase_2","mechanism":"FB 301 is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2).","indications":["Treatment of type 2 diabetes"],"catalyst":""},{"name":"metronidazole 500 mg","genericName":"metronidazole 500 mg","slug":"metronidazole-500-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9COEpZRzE2Sy1kQmhRckd1QzlobUZGYVh1bFg4enJCNDc0RnVhTk5sZVo5elFCeFRGRUl3X2d3ejY3ZjJYNTczSHVsMVlVYlBzRzZsNlRELTdYSGFuOEtabjF1WW1HM2hXWWxNc1RGVQ?oc=5","date":"2025-12-02","type":"pipeline","source":"medwatch.com","summary":"The Novo Nordisk Foundation and the Lundbeck Foundation join forces and invest in new company - medwatch.com","headline":"The Novo Nordisk Foundation and the Lundbeck Foundation join forces and invest in new company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPMDZwdVo3Y0hNaUNzXzNKNjJwRzBfVDhEQ19oaU4tSE1nZ1ZuaFQwVFA2Tmt6ODBEMm0yYXFJYnYwRXZIWGhUeUw4Y0hVMXVTSTI5dTk0LTg3Y2NRbTkzQ1lGRm1FblNEbEJHYk9jYlNWWmx5VEhwaF90WlliMHdBa2RfcmFEQzhiU05aTHptcWRoXzEzNnJCdjRuOA?oc=5","date":"2025-11-13","type":"deal","source":"BioWorld News","summary":"One year later: funding and dealmaking in women’s health - BioWorld News","headline":"One year later: funding and dealmaking in women’s health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9aektFbkZteXNfNDVQYTg0QS1VZUlxVUFtNTBwUmFlcFhJVVppcFc5NGlBUWM1OHpreTJwVmlqZ0ZsNDhGbGxJM05Ia1N6Ukx3dWVJODMtWUxkNVdaeWMzX1c0Nlg0dlBUWWdROWVUSQ?oc=5","date":"2024-10-08","type":"deal","source":"medwatch.com","summary":"Gates Foundation buys into Danish-American biotech company - medwatch.com","headline":"Gates Foundation buys into Danish-American biotech company","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}